The genotoxicity of acrylamide and glycidamide in Big Blue rats

Toxicological Sciences

Volumn 115, Issue 2, 2010, Pages 412-421

  Mei, Nan ^a   McDaniel, Lea P ^a   Dobrovolsky, Vasily N ^a   Guo, Xiaoqing ^a   Shaddock, Joseph G ^a   Mittelstaedt, Roberta A ^a   Azuma, Mizuo ^a   Shelton, Sharon D ^a   McGarrity, Lynda J ^a   Doerge, Daniel R ^b   Heflich, Robert H ^a  

^a Division of Genetic and Reproductive Toxicology   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Acrylamide; Big Blue rat; cII mutant assay; Glycidamide; Hprt mutant assay

Indexed keywords

ACRYLAMIDE; GLYCIDAMIDE;

ANIMAL CELL; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FLUID INTAKE; GENE FREQUENCY; GENE MUTATION; GENOTOXICITY; LYMPHOCYTE; MALE; MICRONUCLEUS; MUTAGENICITY; NONHUMAN; RAT; RETICULOCYTE; SEQUENCE ANALYSIS;

ACRYLAMIDE; ANIMALS; DNA MUTATIONAL ANALYSIS; EPOXY COMPOUNDS; FEMALE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; RATS, TRANSGENIC; SPLEEN;

RATTUS; RODENTIA;

EID: 77954055901     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq069     Document Type: Article

References (50)

1. Adams, W. T., and Skopek, T. R. (1987). Statistical test for the comparison of samples from mutational spectra. J. Mol. Biol. 194, 391-396.
2. Aidoo, A., Mittelstaedt, R. A., Bishop, M. E., Lyn-Cook, L. E., Chen, Y. J., Duffy, P., and Heflich, R. H. (2003). Effect of caloric restriction on Hprt lymphocyte mutation in aging rats. Mutat. Res. 527, 57-66.
3. Bergmark, E. (1997). Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem. Res. Toxicol. 10, 78-84.
4. Besaratinia, A., and Pfeifer, G. P. (2007). A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 28, 519-528.
5. Bowyer, J. F., Latendresse, J. R., Delongchamp, R. R., Muskhelishvili, L., Warbritton, A. R., Thomas, M., Tareke, E., McDaniel, L. P., and Doerge, D. R. (2008). The effects of subchronic acrylamide exposure on gene expression, neurochemistry, hormones, and histopathology in the hypothalamus-pituitary-thyroid axis of male Fischer 344 rats. Toxicol. Appl. Pharmacol. 230, 208-215.
6. Bull, R. J., Robinson, M., Laurie, R. D., Stoner, G. D., Greisiger, E., Meier, J. R., and Stober, J. (1984a). Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res. 44, 107-111.
7. Bull, R. J., Robinson, M., and Stober, J. A. (1984b). Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett. 24, 209-212.
8. Cariello, N. F., Piegorsch, W. W., Adams, W. T., and Skopek, T. R. (1994). Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 15, 2281-2285.
9. Chen, T., Aidoo, A., Mittelstaedt, R. A., Casciano, D. A., and Heflich, R. H. (1999). Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa. Carcinogenesis 20, 269-277.
10. Chico Galdo, V., Massart, C., Jin, L., Vanvooren, V., Caillet-Fauquet, P., Andry, G., Lothaire, P., Dequanter, D., Friedman, M., and Van Sande, J. (2006). Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures. Mol. Cell Endocrinol. 257-258, 6-14.
11. Colonna, M., Grosclaude, P., Remontet, L., Schvartz, C., Mace-Lesech, J., Velten, M., Guizard, A., Tretarre, B., Buemi, A. V., Arveux, P., et al. (2002). Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur. J. Cancer 38, 1762-1768.
12. Dearfield, K. L., Abernathy, C. O., Ottley, M. S., Brantner, J. H., and Hayes, P. F. (1988). Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat. Res. 195, 45-77.
13. Dearfield, K. L., Douglas, G. R., Ehling, U. H., Moore, M. M., Sega, G. A., and Brusick, D. J. (1995). Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutat. Res. 330, 71-99.
14. +/-mouse model for detecting in vivo mutation in an endogenous, autosomal gene. Mutat. Res. 423, 125-136.
15. +/-mice: automated scoring of lymphocyte clones using a fluorescent viability indicator. Environ. Mol. Mutagen. 36, 283-291.
16. Dobrovolsky, V. N., Shaddock, J. G., and Heflich, R. H. (2005). Analysis of in vivo mutation in the hprt and tk genes of mouse lymphocytes. Methods Mol. Biol. 291, 133-144.
17. Doerge, D. R., da Costa, G. G., McDaniel, L. P., Churchwell, M. I., Twaddle, N. C., and Beland, F. A. (2005a). DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat. Res. 580, 131-141.
18. Doerge, D. R., Young, J. F., McDaniel, L. P., Twaddle, N. C., and Churchwell, M. I. (2005b). Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 202, 258-267.
19. Doerge, D. R., Young, J. F., McDaniel, L. P., Twaddle, N. C., and Churchwell, M. I. (2005c). Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol. Appl. Pharmacol. 208, 199-209.
20. Dourson, M., Hertzberg, R., Allen, B., Haber, L., Parker, A., Kroner, O., Maier, A., and Kohrman, M. (2008). Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide. Regul. Toxicol. Pharmacol. 52, 264-289.
21. Fennell, T. R., Snyder, R. W., Krol, W. L., and Sumner, S. C. (2003). Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol. Sci. 71, 164-175.
22. Friedman, M. A., Dulak, L. H., and Stedham, M. A. (1995). A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27, 95-105.
23. Gamboa da Costa, G., Churchwell, M. I., Hamilton, L. P., Von Tungeln, L. S., Beland, F. A., Marques, M. M., and Doerge, D. R. (2003). DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem. Res. Toxicol. 16, 1328-1337.
24. Ghanayem, B. I., Witt, K. L., El-Hadri, L., Hoffler, U., Kissling, G. E., Shelby, M. D., and Bishop, J. B. (2005). Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect. Biol. Reprod. 72, 157-163.
25. Grubbs, F. E. (1969). Procedures for detecting outlying observations in samples. Technometrics 11, 1-21.
26. Hashimoto, K., and Tanii, H. (1985). Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat. Res. 158, 129-133.
27. Hogervorst, J. G., Schouten, L. J., Konings, E. J., Goldbohm, R. A., and van den Brandt, P. A. (2007). A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol. Biomarkers Prev. 16, 2304-2313.
28. International Agency for Research on Cancer. (1995). Acrylamide. IARC Monograph Series 60, 1-45.
29. 6-methylguanine in bone marrow and not in the spleen. Carcinogenesis 17, 2183-2191.
30. Johnson, K. A., Gorzinski, S. J., Bodner, K. M., Campbell, R. A., Wolf, C. H., Friedman, M. A., and Mast, R. W. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85, 154-168.
31. Khan, M. A., Davis, C. A., Foley, G. L., Friedman, M. A., and Hansen, L. G. (1999). Changes in thyroid gland morphology after acute acrylamide exposure. Toxicol. Sci. 47, 151-157.
32. Klaunig, J. E. (2008). Acrylamide carcinogenicity. J. Agric. Food Chem. 56, 5984-5988.
33. Lafferty, J. S., Kamendulis, L. M., Kaster, J., Jiang, J., and Klaunig, J. E. (2004). Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat. Toxicol. Lett. 154, 95-103.
34. Manjanatha, M. G., Aidoo, A., Shelton, S. D., Bishop, M. E., McDaniel, L. P., Lyn-Cook, L. E., and Doerge, D. R. (2006). Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ. Mol. Mutagen. 47, 6-17.
35. Manjanatha, M. G., Shelton, S. D., Aidoo, A., Lyn-Cook, L. E., and Casciano, D. A. (1998). Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene. Mutat. Res. 401, 165-178.
36. Moon, R. C., Janss, D. H., and Young, S. (1969). Preparation of fat cell-"free" rat mammary gland. J. Histochem. Cytochem. 17, 182-186.
37. Moore, M. M., Heflich, R. H., Haber, L. T., Allen, B. C., Shipp, A. M., and Kodell, R. L. (2008). Analysis of in vivo mutation data can inform cancer risk assessment. Regul. Toxicol. Pharmacol. 51, 151-161.
38. Mucci, L. A., Adami, H. O., and Wolk, A. (2006). Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int. J. Cancer 118, 169-173.
39. Paulsson, B., Grawe, J., and Tornqvist, M. (2002). Hemoglobin adducts and micronucleus frequencies in mouse and rat after acrylamide or N-methylolacrylamide treatment. Mutat. Res. 516, 101-111.
40. Paulsson, B., Kotova, N., Grawe, J., Henderson, A., Granath, F., Golding, B., and Tornqvist, M. (2003). Induction of micronuclei in mouse and rat by glycidamide, genotoxic metabolite of acrylamide. Mutat. Res. 535, 15-24.
41. Pelucchi, C., Galeone, C., Levi, F., Negri, E., Franceschi, S., Talamini, R., Bosetti, C., Giacosa, A., and La Vecchia, C. (2006). Dietary acrylamide and human cancer. Int. J. Cancer 118, 467-471.
42. Rice, J. M. (2005). The carcinogenicity of acrylamide. Mutat. Res. 580, 3-20.
43. Rosen, J., and Hellenas, K. E. (2002). Analysis of acrylamide in cooked foods by liquid chromatography tandem mass spectrometry. Analyst 127, 880-882.
44. Segerback, D., Calleman, C. J., Schroeder, J. L., Costa, L. G., and Faustman, E. M. (1995). Formation of N-7-(2-carbamoyl-2-hydroxyethyl)-guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 16, 1161-1165.
45. Tareke, E., Rydberg, P., Karlsson, P., Eriksson, S., and Tornqvist, M. (2002). Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J. Agric. Food Chem. 50, 4998-5006.
46. Thybaud, V., Dean, S., Nohmi, T., de Boer, J., Douglas, G. R., Glickman, B. W., Gorelick, N. J., Heddle, J. A., Heflich, R. H., Lambert, I., et al. (2003). In vivo transgenic mutation assays. Mutat. Res. 540, 141-151.
47. Twaddle, N. C., Churchwell, M. I., McDaniel, L. P., and Doerge, D. R. (2004). Autoclave sterilization produces acrylamide in rodent diets: implications for toxicity testing. J. Agric. Food Chem. 52, 4344-4349.
48. Walker, V. E., Casciano, D. A., and Tweats, D. J. (2009). The Viracept-EMS case: impact and outlook. Toxicol. Lett. 190, 333-339.
49. Young, J. F., Luecke, R. H., and Doerge, D. R. (2007). Physiologically based pharmacokinetic/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humans. Chem. Res. Toxicol. 20, 388-399.
50. Zeiger, E., Recio, L., Fennell, T. R., Haseman, J. K., Snyder, R. W., and Friedman, M. (2009). Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol. Sci. 107, 247-257.